RETAKU
Dead / Abandoned — Abandoned — no statement of use filed (as of 05 Aug 2024)
What this means for you
This application is over — abandoned 05 Aug 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90568455
- Mark type
- Stylized text
- Filed
- 09 Mar 2021
- Published for opposition
- 09 Nov 2021
- Abandoned
- 05 Aug 2024
- Attorney of record
- Kevin S. Costanza
Goods and services
- Class 005 — Pharmaceuticals: Ophthalmic preparations; pharmaceuticals and therapeutic agents for treatment of ophthalmic diseases, namely, therapeutic pharmaceutical for the treatment of ophthalmic diseases, biological pharmaceutical preparations for the treatment of ophthalmic diseases, and gene therapy pharmaceutical preparations for the treatment of ophthalmic diseases
Owner
- Acucela Inc., Seattle, WA, US
- Acucela Inc., Seattle, WA, US
Prosecution history
- 05 Aug 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 05 Aug 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 01 Dec 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Nov 2023 — SOU EXTENSION 4 GRANTED
- 30 Nov 2023 — SOU EXTENSION 4 FILED
- 30 Nov 2023 — SOU TEAS EXTENSION RECEIVED
- 22 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Jun 2023 — SOU EXTENSION 3 GRANTED
- 20 Jun 2023 — SOU EXTENSION 3 FILED
- 20 Jun 2023 — SOU TEAS EXTENSION RECEIVED
- 22 Nov 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Nov 2022 — SOU EXTENSION 2 GRANTED
- 18 Nov 2022 — SOU EXTENSION 2 FILED
- 18 Nov 2022 — SOU TEAS EXTENSION RECEIVED
- 12 May 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED